INTRODUCTION AND OBJECTIVES: Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.
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METHODS: This prospective trial included 150 biopsy-naive men. Men underwent imaging and biopsy and served as their own control. Prebiopsy mpMRI consisted of T2-weighted, diffusionweighted and dynamic contrast-enhanced imaging while CEUS imaging consisted of 4 prostate plane recordings using an US contrast agent and dispersion quantification software. The mpMRI and CEUS with parametric maps were evaluated in blinded fashion by a radiologist and CEUS expert with PIRADSv2 and a 1 to 5 Likert Scale, respectively. A TRUS-guided 12-core SBx was performed by an operator blinded for imaging. A second operator performed a TBx from CEUS suspicious lesions and an MRI TRUS fusion-TBx. Detection rates of csPCa (Gleason score (GS)!7) and insignificant PCa (GS[6) were compared between the biopsy regimens. Negative (NPV) and positive predictive values (PPV) of mpMRI and CEUS for csPCa were determined.
RESULTS: Data of 140 men was available for final analysis. Overall, GS!7 PCa was found in 61 men (44%) and GS[6 PCa in 17 men (12%).
As seen in Table 1 , SBx detected more GS!7 PCa and GS[6 PCa then a MRI-TBx or CEUS-TBx only approach (all p<0.05) while a combination of MRI and CEUS-TBx had equal GS!7 PCa detection (p[0.115). The NPV of MRI and CEUS for GS!7 PCa was comparable (81% vs 83%) while the PPV of MRI was higher than CEUS (83% vs 48%). For the combination of MRI and CEUS, the NPV and PPV was 90% and 52%, respectively.
CONCLUSIONS: Despite avoidance of biopsy in men with GS[6 PCa, a MRI-TBx or CEUS-TBx only approach missed GS!7 PCa as compared to SBx. A combination of MRI and CEUS-TBx demonstrated equal detection of GS!7 PCa as compared to SBx. mpMRI and CEUS have comparable detection rates but mpMRI provided higher sampling efficiency than CEUS.
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INTRODUCTION AND OBJECTIVES: We previously presented post prostatectomy pathology results from a small number of prostate cancer (PCa) patients who did not have findings suggestive of cancer on pre-operative pelvic magnetic resonance imaging (MRI). We update our series with findings from more patients with the same imaging characteristics.
